Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01961778 · ClinicalTrials.gov registry record · NA
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
A NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01961778: Completed NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.
NCT01961778 is a NA study of Barrett's Esophagus that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 522-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01961778, a NA study of Barrett's Esophagus, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective randomized study comparing radiofrequency ablation and cryotherapy for the endoscopic treatment of Barrett's esophagus. The study is powered to assess clinical equivalence (non-inferior) of the treatment regimens.
Primary Outcome
The primary endpoint of this study is the percentage of Barrett's esophagus ablated during the initial treatment session.
Conditions Studied
Interventions
- DEVICE Cryotherapy
- DEVICE Radio-Frequency Ablation
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-11 |
| Est. Completion | 2020-02-01 |
| Phase | NA |
What the finished NCT01961778 record still lists
NCT01961778 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 522-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Barrett's Esophagus appearing as the primary indexed condition, and to 2 interventions - of which Cryotherapy is the first listed.
NCT01961778 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01961778 about?
NCT01961778 is a clinical study titled "Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma". Prospective randomized study comparing radiofrequency ablation and cryotherapy for the endoscopic treatment of Barrett's esophagus. The study is powered to assess clinical equivalence (non-inferior) of the treatment regimens.
What is the current status of trial NCT01961778?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-11. Estimated completion is 2020-02-01.
What conditions does trial NCT01961778 study?
This clinical trial studies the following conditions: Barrett's Esophagus.
What interventions are being tested in trial NCT01961778?
The interventions under investigation include: Cryotherapy (DEVICE), Radio-Frequency Ablation (DEVICE).
Who is sponsoring clinical trial NCT01961778?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01961778 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01961778's enrollment target sits among peer trials
50 16th of 22 higher than 7 of 22 other Barrett's Esophagus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Barrett's Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
RECRUITING · NA
-
Navicam for Detection of Barrett's Esophagus
RECRUITING · NA
-
Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule
ACTIVE NOT RECRUITING · NA
-
Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
COMPLETED · NA
-
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
COMPLETED · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia